Phase 2 Placebo Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Oxytocin Plus Self-compassion Training in Borderline Personality Disorder
Self-compassion Training (SCT) Plus Intranasal OxytocinSelf-compassion Training (SCT) Plus Intranasal Placebo
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau80 enrolled1 locationNCT07551882
Recruiting
Phase 2
Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy
EsophagogastroduodenoscopySimethiconeN-Acetylcysteine+7 more
Hospital General de Mexicali132 enrolled2 locationsNCT07245095
Recruiting
Phase 2
Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
PlaceboSuvorexant
Johns Hopkins University120 enrolled1 locationNCT05145764
Recruiting
Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
PainVirtual RealityPlacebo
University of Maryland, Baltimore182 enrolled1 locationNCT03897998
Recruiting
Phase 1Phase 2
Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels
Depression - Major Depressive DisorderTranscranial Magnetic StimulationPlacebo
Universidad de Guanajuato40 enrolled1 locationNCT06667180
Completed
Phase 2
A pilot trial of vitamin D for the reduction of chronic disease and mortality in older adults.
This trial is using healthy volunteers from the electoral roll. The overall aim of this study is to determine the feasibility and inform the design of a large-scale randomised, placebo-controlled chemoprevention trial of vitamin D3 (cholecalciferol) for the reduction of total mortality.
Queensland Institute of Medical Research660 enrolled1 locationACTRN12609001063202